Morosini Deborah
SEC CIK 1824625 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | EVP, Chief of Clinical Affairs | 3,460 | — | $830.3K | 4 | 2021-11-16 | 2021-12-15 |
Most active insiders at PRLD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bonita David P | Dir, 10% | $12.50M | — |
| 2 | ORBIMED ADVISORS LLC | Dir, 10% | $12.50M | — |
| 3 | Huang Jane | Pres, CMO | — | — |
| 4 | RA CAPITAL MANAGEMENT, L.P. | 10% | — | — |
Morosini Deborah made no open-market trades at PRLD in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-17 | 2021-12-15 | PRLD | Prelude Therapeutics Inc | Morosini Deborah | EVP, Chief of Clinical Affairs | M - OptEx | $11.70 | +28.8K | 3,460 | New | +$336.4K |
| D | 2021-12-17 | 2021-12-15 | PRLD | Prelude Therapeutics Inc | Morosini Deborah | EVP, Chief of Clinical Affairs | S - Sale+OE | $13.00 | -28.8K | 444 | -98% | -$373.8K |
| DM | 2021-11-18 | 2021-11-16 | PRLD | Prelude Therapeutics Inc | Morosini Deborah | EVP, Chief of Clinical Affairs | S - Sale+OE | $15.88 | -28.8K | 844 | -97% | -$456.5K |
| D | 2021-11-18 | 2021-11-16 | PRLD | Prelude Therapeutics Inc | Morosini Deborah | EVP, Chief of Clinical Affairs | M - OptEx | $12.85 | +28.8K | 29.2K | +6,475% | +$369.5K |
Purchase Sale Sale after option exercise All abbreviations